10.1002/chem.202003850
Chemistry - A European Journal
FULL PAPER
3.35 (td, J = 10.3, 4.9 Hz, 1H, H-5); 13C-NMR (126 MHz, CDCl3) δ 137.5
(C, Ar), 129.0 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar), 102.2 (CH-1),
101.7 (O-CH-O), 82.9 (d, J = 169.7 Hz, CH2-F), 80.1 (CH-3), 78.8 (CH-2),
78.7 (CH-4), 68.9 (d, J = 19.7 Hz, CH2-CH2-F), 68.6 (CH2-6), 67.49 (CH-
5), 62.3 (OCH3), 59.0 (OCH3). HRMS (ESI) m/z calcd for C17H23FNaO6
[M+Na]+: 365.13709, found: 365.13753.
by flash silica gel chromatography (hexane/ethyl acetate 9:1 to 7:3) to give
exclusively glycoside 3b- (110 mg, 58 %). 1H-NMR (300 MHz, CDCl3) δ
7.53-7.42 (m, 3H, Ar), 7.41-7.30 (m, 2H, Ar), 5.54 (s, 1H, O-CH-O), 5.05
(d, J = 3.8 Hz, 1H, H-1), 4.27 (dd, J = 9.8, 4.6 Hz, 1H, H-6eq), 4.06-3.95
(m, 2H, CH2-CF3), 3.89-3.81 (m, 1H, H-5), 3.72 (t, J = 9.8 Hz, 1H, H-6ax),
3.71 (t, J = 9.2, 1H, H-3) 3.65 (s, 3H, OCH3), 3.54 (s, 3H, OCH3), 3.33 (t,
J = 9.2 Hz, 1H, H-4), 3.33 (dd, J = 9.2, 3.8, Hz, 1H, H-2); 13C-NMR (101
MHz, CDCl3) δ 145.4 (C, Ar), 131.2 (CH, Ar), 129.5 (2 CH, Ar), 123.8 (q, J
= 277.1 Hz, CF3), 124.9 (2 CH, Ar), 101.5 (O-CH-O), 97.2 (CH-1), 81.9
(CH-4), 81.0 (CH-2), 79.3 (CH-3), 68.8 (CH2-6), 64.7 (q, J = 35.0 Hz, CH2-
CF3), 63.1 (CH-5), 61.2 (OCH3), 59.1 (OCH3). HRMS (ESI) m/z calcd for
C17H21F3NaO6 [M+Na]+: 401.11879, found: 401.12319.
Synthesis of 2-propyl 4,6-O-benzylidene-2,3-di-O-methyl-/-D-
mannopyranoside (1d-/): Glycosyl sulfoxide 1 (158 mg, 0.39 mmol)
and 2-propanol (0.12 mL, 1.56 mmol) were coupled following the general
procedure II (-45 ºC, 1 h). After work up, the residue was purified by flash
silica gel chromatography (hexane/ethyl acetate 9:1 to 8:2) to give
glycoside 1d- (5 mg, 4 %), along with glycoside 1d- (20 mg, 15 %).
Similarly, glycosyl sulfoxide 2 (123 mg, 0.30 mmol) and 2-propanol (0.09
mL, 1.22 mmol) were also coupled following the general procedure II (-50
ºC, 1 h). After work up, the residue was purified by flash silica gel
chromatography (hexane/ethyl acetate 9:1 to 8:2) to give exclusively
glycoside 1d-(21 mg, 20 %). For 1d-: 1H-NMR (400 MHz, CDCl3) δ
7.54-7.44 (m, 2H, Ar), 7.41-7.29 (m, 3H, Ar), 5.59 (s, 1H, O-CH-O), 4.98
(d, J = 1.7 Hz, 1H, H-1), 4.27-4.17 (m, 1H, H-6a), 4.06 (t, J = 9.0 Hz, 1H,
H-4), 3.93 (hept, J = 6.2 Hz, 1H, CH3-CH-CH3), 3.86-3.80 (m, 2H, H-5, H-
6b), 3.74 (dd, J = 9.9, 3.3 Hz, 1H, H-3), 3.59 (dd, J = 3.3, 1.7 Hz, 1H, H-2),
3.57 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 1.23 (d, J = 6.2 Hz, 3H, CH3-CH-
CH3), 1.17 (d, J = 6.1 Hz, 3H, CH3-CH-CH3); 13C-NMR (101 MHz, CDCl3)
δ 137.7 (C, Ar), 128.9 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar), 101.6
(O-CH-O), 96.5 (CH-1), 79.53 (CH-2), 79.50 (CH-4), 77.8 (CH-3), 69.6
(CH3-CH-CH3), 69.0 (CH2-6), 64.1 (CH-5), 59.9 (OCH3), 59.2 (OCH3), 23.4
(CH3-CH-CH3), 21.4 (CH3-CH-CH3). HRMS (ESI) m/z calcd for
C18H26NaO6 [M+Na]+: 361.16092, found: 361.16216. For 1d-: 1H-NMR
(400 MHz,CDCl3) δ 7.56-7.38 (m, 3H, Ar), 7.37 (s, 2H, Ar), 5.55 (s, 1H, O-
CH-O), 4.59 (d, J = 1.0 Hz, 1H, H-1), 4.29 (dd, J = 10.5, 4.9 Hz, 1H, H-
6eq), 4.04 (t, J = 9.6 Hz, 1H, H-4), 4.01 (hept, J = 6.3 Hz, 1H, CH3-CH-
CH3), 3.90 (t, J = 10.3 Hz, 1H, H-6ax), 3.69 (dd, J = 3.2, 1.0 Hz, 1H, H-2),
3.67 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 3.42 (dd, J = 9.9, 3.2 Hz, 1H, H-
3), 3.33 (ddd, J = 10.0, 9.2, 4.9 Hz, 1H, H-5), 1.26 (d, J = 6.2 Hz, 3H, CH3-
CH-CH3), 1.19 (d, J = 6.1 Hz, 3H, CH3-CH-CH3); 13C-NMR (101 MHz,
CDCl3) δ 137.6 (C, Ar), 128.9 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar),
101.7 (O-CH-O), 100.1 (CH-1), 80.3 (CH-3), 79.7 (CH-2), 78.8 (CH-4),
71.4 (CH3-CH-CH3), 68.7 (CH2-6), 67.4 (CH-5), 62.2 (OCH3), 58.9 (OCH3),
23.6 (CH3-CH-CH3), 21.7 (CH3-CH-CH3). HRMS (ESI) m/z calcd for
C18H26NaO6 [M+Na]+: 361.16092, found: 361.16164.
Synthesis of 2-fluoroethyl 4,6-O-benzylidene-2,3-di-O-methyl-/-D-
glucopyranoside (3c-/): Glycosyl sulfoxide 3 (153 mg, 0.38 mmol) and
2-fluoroethanol (0.09 mL, 1.51 mmol) were coupled following the general
procedure II (-60 ºC, 1 h). After work up, the residue was purified by flash
silica gel chromatography (hexane/ethyl acetate 9:1 to 7:3) to give
glycoside 3c- (26 mg, 20 %) along with glycoside 3c- (6 mg, 5 %). For
3c-:1H-NMR (400 MHz, CDCl3) δ 7.54 -7.41 (m, 2H, Ar), 7.39-7.32 (m,
3H, Ar), 5.54 (s, 1H, O-CH-O), 5.03 (d, J = 3.8 Hz, 1H, H-1), 4.62 (dt, J =
47.6, 4.4 Hz, 2H, CH2-F), 4.27 (dd, J = 10.2, 4.8 Hz, 1H, H-6eq), 3.99-3.76
(m, 3H, CH2-CH2-F, H-5), 3.72 (t, J = 9.3 Hz, 1H, H-4), 3.71 (t, J = 10.2 Hz,
1H, H-6ax), 3.65 (s, 3H, OCH3), 3.55 (s, 3H, OCH3), 3.54 (t, J = 9.3 Hz,
1H, H-3), 3.32 (dd, J = 9.3, 3.8 Hz, 1H, H-2); 13C-NMR (101 MHz, CDCl3)
δ 137.4 (C, Ar), 129.0 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar), 101.4
(O-CH-O), 97.6 (CH-1), 82.5 (d, J = 169.8 Hz, CH2-F), 82.3 (CH-3) 81.3
(CH-2), 79.8 (CH-4), 69.1 (CH2-6), 67.2 (d, J = 20.2 Hz, CH2-CH2-F), 62.5
(CH-5), 61.1 (OCH3), 59.1 (OCH3). HRMS (ESI) m/z calcd for
C17H23FNaO6 [M+Na]+: 365.13709, found: 365.13708. For 3c-1H-NMR
(400 MHz, CDCl3) δ 7.50-7.48 (m, 2H, Ar), 7.42-7.29 (m, 3H, Ar), 5.54 (s,
1H, O-CH-O), 4.70-4.49 (m, 2H, CH2-F), 4.45 (d, J = 7.6 Hz, 1H, H-1), 4.32
(dd, J = 10.3, 5.0 Hz, 1H, H-6eq), 4.07 (dddd, J = 31.3, 12.1, 4.6, 3.0 Hz,
1H, CH2-CH2-F), 3.86 (dddd, J = 26.5, 12.2, 5.9, 3.4 Hz, 1H, CH2-CH2-F),
3.76 (t, J = 10.3 Hz, 1H, H-6ax), 3.64 (s, 3H, OCH3), 3.62 (s, 3H, OCH3),
3.57 (t, J = 9.3 Hz, 1H, H-4), 3.39 (t, J = 9.2 Hz, 1H, H-3), 3.42-3.35 (m,
1H, H-5), 3.12 (dd, J = 9.2, 7.6 Hz, 1H, H-2); 13C-NMR (101 MHz, CDCl3)
δ 137.4 (C, Ar), 129.1 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar), 104.2
(CH-1), 101.3 (O-CH-O), 83.8 (CH-2), 84.3 (d, J = 170.4 Hz, CH2-F), 82.6
(CH-3), 81.3 (CH-4), 69.2 (d, J = 20.1 Hz, CH2-CH2-F), 68.8 (CH2-6), 66.1
(CH-5), 61.1 (OCH3), 61.0 (OCH3). HRMS (ESI) m/z calcd for C17H24FO6
[M+H]+: 343.15514, found: 343.15362.
Synthesis of 4,6-O-benzylidene-2,3-di-O-methyl--D-glucopyranosyl-
(1
→
6)-1,2:3,4-di-O-isopropylidene--D-galactopyranose (3a-):
Synthesis of 2-propyl 4,6-O-benzylidene-2,3-di-O-methyl-/-D-
glucopyranoside (3d-/): Glycosyl sulfoxide 3 (105 mg, 0.26 mmol) and
2-propanol (0.08 mL, 1.04 mmol) were coupled following the general
procedure II (-60 ºC, 1 h). After work up, the residue was purified by flash
silica gel chromatography (hexane/ethyl acetate 9:1 to 7:3) to give
glycoside 3d- (17 mg, 19 %) along with glycoside 3d- (7 mg, 8 %). For
Glycosyl sulfoxide 3 (142 mg, 0.35 mmol) and 1,2:3,4-di-O-isopropylidene-
-D-galactose (128 mg, 0.46 mmol) were coupled following the general
procedure I (-60 ºC, 1 h). After work up, the residue was purified by flash
silica gel chromatography (hexane/ethyl acetate 8:2 to 7:3) to give
exclusively glycoside 3a- (53 mg, 28 %). 1H-NMR (500 MHz, CDCl3) δ
7.54-7.46 (m, 2H, Ar), 7.39-7.30 (m, 3H, Ar), 5.54 (s, 1H, O-CH-O), 5.52
(d, J = 5.0 Hz, 1H, H-1), 5.05 (d, J = 3.7 Hz, 1H, H-1´), 4.62 (dd, J = 8.0,
2.4 Hz, 1H, H-3), 4.33 (dd, J = 8.0, 1.9 Hz, 1H, H-4), 4.31 (dd, J = 5.0, 2.4
Hz, 1H, H-2), 4.28 (dd, J = 10.3, 5.1 Hz, 1H, H-6eq´), 4.05 (td, J = 6.7, 1.9
Hz, 1H, H-5), 3.89 (td, J = 9.9, 4.9 Hz, 1H, H-5), 3.82 (dd, J = 10.5, 6.3 Hz,
1H, H-6a), 3.74 (dd, J = 10.4, 7.1 Hz, 1H, H-6b), 3.70 (t, J = 10.3,1H, H-
6ax´), 3.68 (t, J = 9.3 Hz, 1H, H-3´) 3.63 (s, 3H, OCH3), 3.53 (t, J = 9.3 Hz,
1H, H-4´) 3.51 (s, 3H, OCH3), 3.29 (dd, J = 9.3, 3.7 Hz, 1H, H-2´), 1.54 (s,
3H, CH3), 1.44 (s, 3H, CH3), 1.33 (s, 6H, 2 CH3); 13C-NMR (126 MHz,
CDCl3) δ 137.6 (C, Ar), 129.0 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar),
109.3 (O-C-O), 108.7 (O-C-O), 101.4 (O-CH-O), 97.6 (CH-1´), 96.4 (CH-
1), 82.3 (CH-4´), 81.3 (CH-2´), 79.4 (CH-3´), 70.9 (CH-2), 70.8 (CH-3),
70.7 (CH-4), 69.1 (CH2-6´), 67.0 (CH2-6), 65.9 (CH-5), 62.4 (CH-5´), 61.1
(OCH3), 58.4 (OCH3), 26.2 (CH3), 26.1 (CH3), 25.0 (CH3), 24.5 (CH3).
HRMS (ESI) m/z calcd for C27H42NO11 [M+NH4]+: 556.27524, found:
556.27532.
1
3d-α: H-NMR (400 MHz, CDCl3) δ 7.64-7.44 (m, 2H, Ar), 7.42-7.30 (m,
3H, Ar), 5.55 (s, 1H, O-CH-O), 5.06 (d, J = 3.8 Hz, 1H, H-1), 4.26 (dd, J =
10.3, 4.8 Hz, 1H, H-6eq), 3.93 (hept, J = 6.3 Hz, 1H, CH3-CH-CH3), 3.71
(t, J = 10.3 Hz, 1H, H-6ax), 3.70 (t, J = 9.3 Hz, 1H, H-3), 3.65 (s, 3H, OCH3),
3.60-3.57 (m, 1H, H-5), 3.53 (t, J = 9.3 Hz, 1H, H-4), 3.52 (s, 3H, OCH3),
3.28 (dd, J = 9.3, 3.8 Hz, 1H, H-2), 1.27 (d, J = 6.3 Hz, 3H, CH3-CH-CH3),
1.22 (d, J = 6.3 Hz, 3H, CH3-CH-CH3); 13C-NMR (101 MHz, CDCl3) δ 137.5
(C, Ar), 129.0 (CH, Ar), 128.3 (2 CH, Ar), 126.2 (2 CH, Ar), 101.4 (O-CH-
O), 95.3 (CH-1), 82.6 (CH-4), 81.4 (CH-2), 79.6 (CH-3), 69.8 (CH3-CH-
CH3), 69.2 (CH2-6), 62.4 (CH-5), 61.1 (OCH3), 58.8 (OCH3), 23.4 (CH3-
CH-CH3), 21.4 (CH3-CH-CH3). HRMS (ESI) m/z calcd for C18H26NaO6
[M+Na]+: 361.16216, found: 361.16278. For 3d-: 1H-NMR (400
MHz,CDCl3) δ 7.66-7.42 (m, 2H, Ar), 7.42-7.30 (m, 3H, Ar), 5.53 (s, 1H,
O-CH-O), 4.45 (d, J = 7.7 Hz, 1H, H-1), 4.31 (dd, J = 10.3, 5.0 Hz, 1H, H-
6eq), 3.98 (hept, J = 6.1 Hz, 1H, CH3-CH-CH3), 3.76 (t, J = 10.3 Hz, 1H,
H-6ax), 3.63 (s, 3H, OCH3), 3.61 (s, 3H, OCH3), 3.56 (t, J = 9.3 Hz, 1H, H-
4), 3.45-3.28 (m, 2H, H-5, H-3), 3.06 (dd, J = 8.8, 7.7 Hz, 1H, H-2), 1.26
(d, J = 6.1 Hz, 3H, CH3-CH-CH3), 1.23 (d, J = 6.1 Hz, 3H, CH3-CH-CH3);
13C-NMR (101 MHz, CDCl3) δ 137.5 (C, Ar), 129.0 (CH, Ar), 128.3 (2 CH,
Ar), 126.2 (2 CH, Ar), 102.7 (CH-1), 101.3 (O-CH-O), 84.0 (CH-2), 82.8
(CH-3), 81.4 (CH-4), 72.8 (CH3-CH-CH3), 67.0 (CH2-6), 66.0 (CH-5), 61.1
Synthesis of 2,2,2-trifluoroethyl 4,6-O-benzylidene-2,3-di-O-methyl--
D-glucopyranoside (3b-): Glycosyl sulfoxide 3 (202 mg, 0.50 mmol) and
2,2,2-trifluoroethanol (0.14 mL, 1.99 mmol) were coupled following the
general procedure II (-60 ºC, 1 h). After work up, the residue was purified
10
This article is protected by copyright. All rights reserved.